Freestyle libre 3 plus sensors
Ended Awarded
- Contract number
- SPE2DR26FM3M9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,561
Award facts
- Contract value 100% obligated
- $18,560.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,560.73 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 12, 2025, with completion expected by November 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The Freestyle Libre 3 Plus is a continuous glucose monitoring system used for diabetes management, reflecting the Defense Logistics Agency's ongoing commitment to supplying essential medical devices and pharmaceuticals to support military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive range of medications, medical devices, and specialized healthcare commodities globally. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements across multiple therapeutic domains and customer bases within the Department of Defense healthcare ecosystem.
Quick answers
Who was awarded contract SPE2DR26FM3M9?
SPE2DR26FM3M9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FM3M9 worth?
The government has obligated $18,561 on SPE2DR26FM3M9.
Is contract SPE2DR26FM3M9 an order under another contract?
Yes. SPE2DR26FM3M9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM3M9 competed?
The extent of competition for SPE2DR26FM3M9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award